Risk associated with a systematic search of extended-spectrum β-lactamase-producing Enterobacteriaceae

Roberta Prinapori1, Julie Guinaud, Antoine Khalil

  • 1Infectious Disease Department, Necker-Enfants-Malades Hospital, AP-HP, Université Paris-Descartes, Paris, France.

Insights

Hospitalized children with previous ESBL colonization often received excessive carbapenem antibiotics. Most antibiotic courses required deescalation, highlighting the need for programs to reduce carbapenem use and combat resistance.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pediatrics

Background:

  • Extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae colonization is a growing concern in pediatric populations.
  • Hospitalized children with suspected infections often receive broad-spectrum antibiotics, including carbapenems.

Purpose of the Study:

  • To evaluate antibiotic prescribing patterns in hospitalized children with prior ESBL colonization.
  • To assess the appropriateness of carbapenem use and the feasibility of deescalation in this patient group.

Main Methods:

  • Retrospective evaluation of 74 hospitalized children with previous fecal ESBL colonization.
  • Analysis of antibiotic therapy, focusing on carbapenem use and subsequent deescalation rates.

Main Results:

  • 86.5% of patients received carbapenem agents, despite only 3 patients (4%) being infected with ESBL-producing Enterobacteriaceae.
  • 95% of initial antibiotic courses were deemed excessive and candidates for deescalation.
  • Successful deescalation was achieved in only 62% of appropriate cases.

Conclusions:

  • Carbapenem use is frequently excessive in hospitalized children with prior ESBL colonization.
  • Deescalation of antibiotic therapy is challenging, indicating a need for improved stewardship.
  • Implementing ESBL control programs can reduce carbapenem use and mitigate the rise of gram-negative bacilli resistance.

Related Concept Videos

Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Antibiotic Selection00:57

Antibiotic Selection

Overview